No products from this compounder that are marked as sterile should be administered to patients, as microbial contamination can put patients at risk for severe infections.
Hospitals and healthcare providers should quarantine any such products and await further instructions, according to the release.
More Articles on Anesthesia:
Sedasys Computer-Assisted System for GI Propofol Sedation Approved by FDA
FDA Clears Masimo’s Rainbow Respiratory Monitor for Pediatric Use
Hospira GemStar Infusion System Recalled by FDA for Battery Malfunction
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.